Moderna | Capital Ordinaire



Ordinary Share Capital Changement Date
Acadia Pharmaceuticals USD 16K 0 2024-12
Adcock Ingram Holdings ZAR 14.68M 427K 2024-06
Agios Pharmaceuticals USD 73K 0 2024-12
Alnylam Pharmaceuticals USD 1.29M 4K 2024-12
Amgen USD 33.53B 140M 2024-12
Arrowhead Research USD 218K 1000 2024-12
Biogen USD 100K 0 2024-12
BioMarin Pharmaceutical USD 191K 0 2024-12
Celltrion KRW 220.45B 27.97M 2024-09
Cspc Pharmaceutical CNY 11.03B 26.91M 2024-12
Dianthus Therapeutics USD 31K 2K 2024-12
Gilead Sciences USD 1000K 0 2024-12
GlaxoSmithKline GBP 1.35B 0 2024-12
Incyte USD 193K 1000 2024-12
Ionis Pharmaceuticals USD 158K 0 2024-12
Kangmei Pharma CNY 13.86B 0 2024-09
Knight Therapeutics CAD 539.32M 1.63M 2024-09
Laboratorios Farma EUR 3.24M 0 2023-06
Malin Corporation EUR 200K 0 2024-06
Moderna USD 38.6K 100 2024-12
Organigram Holdings CAD 892.59M 39.7M 2024-12
Pharma Mar EUR 10.93M 80K 2024-12
Qiagen NV USD 2.6M 0 2024-09
Regeneron Pharmaceuticals USD 102K 0 2024-12
Sarepta Therapeutics USD 10K 0 2024-12
Sartorius EUR 69M 0 2025-03
Sino Biopharmaceutical CNY 414.38M 0 2024-12
Tilray USD 93K 5K 2024-11
Ultragenyx Pharmaceutical USD 92K 0 2024-12
United Therapeutics USD 800K 100K 2024-12
Vertex Pharmaceuticals USD 2.6M 0 2024-12
Zz Pientze Pharmaceu 603.32M 0 2024-09



Moderna Capital Ordinaire - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.